CN114410662A - Method for improving expression efficiency of glucose oxidase gene in pichia pastoris - Google Patents

Method for improving expression efficiency of glucose oxidase gene in pichia pastoris Download PDF

Info

Publication number
CN114410662A
CN114410662A CN202210153176.5A CN202210153176A CN114410662A CN 114410662 A CN114410662 A CN 114410662A CN 202210153176 A CN202210153176 A CN 202210153176A CN 114410662 A CN114410662 A CN 114410662A
Authority
CN
China
Prior art keywords
god
glucose oxidase
gene sequence
seq
fad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210153176.5A
Other languages
Chinese (zh)
Other versions
CN114410662B (en
Inventor
曹云鹤
董冰
黄菲
王春林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN202210153176.5A priority Critical patent/CN114410662B/en
Publication of CN114410662A publication Critical patent/CN114410662A/en
Application granted granted Critical
Publication of CN114410662B publication Critical patent/CN114410662B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07002FAD synthetase (2.7.7.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the technical field of genetic engineering, in particular to a method for improving the expression efficiency of a glucose oxidase gene in pichia pastoris. The invention obtains the gene sequence shown in SEQ ID NO.2 by optimizing the original gene sequence of the Aspergillus niger Glucose Oxidase (GOD) and manually adjusting partial basic groups. The method provided by the invention constructs the gene sequence shown in SEQ ID NO.2 and the Flavin Adenine Dinucleotide (FAD) synthetase gene sequence shown in SEQ ID NO.3 in recombinant bacteria at the same time; the fermentation activity of glucose oxidase generated by the strain co-expressing the FAD synthetase gene and the GOD gene reaches 2.2 times of that of the strain singly expressing the GOD gene.

Description

Method for improving expression efficiency of glucose oxidase gene in pichia pastoris
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a high-efficiency expression method of a glucose oxidase gene in pichia pastoris.
Background
The system of Glucose Oxidase (GOD) is named as beta-D-glucose oxidoreductase (EC 1.1.3.4). GOD was first discovered by Muller in Aspergillus niger (Aspergillus niger) in 1928 and catalyzes the formation of gluconic acid and hydrogen peroxide from beta-D-glucose using molecular oxygen as an electron acceptor. In addition, GOD also has a slower oxidation of mannose, galactose and xylose. The enzyme has been widely used in the food industry and in medical diagnostics and research. The glucose oxidase is an important novel enzyme preparation for feed, can ensure the intestinal health of livestock and poultry, improve the digestion performance, promote the growth of animals and relieve the mycotoxin poisoning symptom to a certain extent.
GOD is a homodimeric enzyme, two subunits joined by two disulfide bonds, each containing two distinct regions: a region that binds Flavin Adenine Dinucleotide (FAD) in a non-covalent bond, the region being predominantly beta-sheet; the other region binds the substrate β -D-glucose, which is supported by four α -helices in an antiparallel β -sheet. Studies have shown that the dimeric form is more stable than the monomer; when FAD is cleaved from the monomeric enzyme, the stability of the monomer becomes worse, indicating that FAD plays an important role in either GOD activity or stability.
The process of oxidizing beta-D-glucose by glucose oxidase is divided into two half reactions, as shown in figure 1, in the reduction half reaction, the glucose oxidase oxidizes the beta-D-glucose to generate D-glucose-delta-lactone, the D-glucose-delta-lactone is spontaneously degraded to gluconic acid, and then the prosthetic group FAD on the glucose oxidase is reduced to FADH2(ii) a In the oxidation half-reaction, FADH2Quilt O2Oxidation to FAD and H2O2. Since synthesis of FAD in cells is catalyzed by FAD Synthetase (FADs), overexpression of FAD synthetase can increase the amount of FAD synthesized and thus the amount of glucose oxidase expressed.
Disclosure of Invention
The invention aims to provide a method for highly expressing glucose oxidase with stable activity.
In the first aspect, the invention provides an optimized glucose oxidase gene sequence, wherein pichia pastoris high-frequency codons are used for replacing low-frequency codons, and restriction enzyme cutting sites such as EcoRI, Xba I, Sac I and the like are removed. In addition, the content of A, T bases in the sequence is adjusted through manual adjustment, so that a plurality of continuous A, T bases are avoided, and a glucose oxidase gene sequence which can be co-expressed with FAD synthetase in the same recombinant bacterium is obtained.
Specifically, the gene sequence of the glucose oxidase provided by the invention is shown in SEQ ID NO. 2.
In a second aspect, the invention claims expression vectors containing the glucose oxidase gene sequence shown in SEQ ID NO. 2.
In a third aspect, the invention claims recombinant bacteria containing a glucose oxidase gene sequence shown as SEQ ID NO. 2.
The recombinant strain provided by the invention simultaneously expresses a glucose oxidase gene sequence shown by SEQ ID NO.2 and a flavin adenine dinucleotide synthetase gene sequence shown by SEQ ID NO. 3.
The invention also provides a method for improving the activity and the expression efficiency of the glucose oxidase, and the recombinant bacterium co-expressed by the glucose oxidase gene sequence shown in SEQ ID NO.2 and the flavin adenine dinucleotide synthetase gene sequence shown in SEQ ID NO.3 is constructed.
In the method provided by the invention, a recombinant expression vector pPIC-GOD-opt containing a glucose oxidase gene sequence shown in SEQ ID No.2 is constructed by adopting a vector pPICz alpha A; an expression vector pGAP-FAD containing a flavin adenine dinucleotide synthetase gene sequence shown in SEQ ID NO.3 is constructed by using the vector pGAPkA.
Specifically, the method provided by the invention comprises the following steps:
(1) optimizing the gene sequence shown in SEQ ID NO.1 to obtain a glucose oxidase gene sequence GOD-opt shown in SEQ ID NO.2, and introducing EcoRI and Xba I enzyme cutting sites at the 5 'and 3' ends of the GOD-opt;
(2) carrying out enzyme digestion on the GOD-opt and the pPICz alpha A vector by EcoRI and Xba I respectively to obtain a recombinant expression vector pPIC-GOD-opt;
(3) the pPIC-GOD-opt is linearized by Sac I restriction endonuclease, and the linearized pPIC-GOD-opt is transferred into a pichia pastoris competent cell to obtain a recombinant strain X33/GOD;
(4) carrying out double enzyme digestion on a gene sequence shown in SEQ ID NO.3 and an expression vector pGAPkA to obtain a recombinant expression vector pGAP-FAD;
(5) and transferring the recombinant expression vector pGAP-FAD into a recombinant bacterium X33/GOD to obtain a strain X33/GOD-FAD with the co-expression of FAD synthetase genes and GOD genes.
In the method provided by the invention, the primer sequence used for synthesizing the gene sequence shown by SEQ ID NO.3 is shown as SEQ ID NO. 6-7.
According to the understanding of the technical personnel in the field, the invention claims the application of the glucose oxidase gene sequence shown as SEQ ID NO.2 or the recombinant bacteria in improving the expression quantity of the glucose oxidase.
And the glucose oxidase gene sequence shown in SEQ ID NO.2 or the application of the recombinant bacterium in improving the expression activity of the glucose oxidase.
The invention has the beneficial effects that the expression efficiency of GOD is improved through the co-expression of FAD synthetase.
According to the invention, a pichia pastoris high-frequency codon is replaced by a low-frequency codon, restriction enzyme cutting sites such as EcoRI, Xba I and Sac I are removed, manual adjustment is carried out, and the content of A, T bases in the sequence is adjusted, so that a glucose oxidase gene sequence which can be co-expressed with FAD synthetase in the same recombinant bacterium is obtained and is shown as SEQ ID No. 2.
The gene sequence shown in SEQ ID NO.2 and the Flavin Adenine Dinucleotide (FAD) synthetase gene sequence shown in SEQ ID NO.3 are simultaneously constructed in recombinant bacteria; the fermentation activity of glucose oxidase generated by the FAD synthetase gene and GOD gene coexpression strain is 2.2 times of that of GOD gene single expression strain; and the expression quantity of glucose oxidase generated by the strain co-expressing the FAD synthetase gene and the GOD gene is obviously improved.
Drawings
FIG. 1 shows the result of PCR amplification of FAD synthetase gene according to the present invention. Wherein, lane 1 is DNA Marker; lane 2 shows FAD synthetase gene.
FIG. 2 is the relative catalytic activity of shake flask fermented GOD.
FIG. 3 is an SDS-PAGE electrophoresis of fermentation supernatants. Wherein M is a protein molecular weight standard; lane 1 is X33/GOD fermentation supernatant; lane 2 is X33/GOD-FAD-1 fermentation supernatant; lane 3 is X33/GOD-FAD-2 fermentation supernatant; lane 4 is X33/GOD-FAD-3 fermentation supernatant; lane 5 is X33/GOD-FAD-4 fermentation supernatant.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
In the examples of the present invention, pichia pastoris expression vector pPICz α a and strain X33 were purchased from Invitrogen. The pGAPkA expression vector was constructed and stored in this laboratory. Coli Top10 competent cells were purchased from Biotechnology Ltd of New Engineers of Kyoto, Beijing.
The BCA protein quantitative analysis kit used in the embodiment of the invention is a product of Pierce company of America; PR1910 protein molecular weight standard and horseradish peroxidase, the manufacturer is a product of Solebao company in China; antibiotic Zeocin, manufactured by Invitrogen, usa; glucose oxidase standard, o-dianisidine, Sigma-Aldrich in USA; restriction enzyme, Phusion DNA polymerase, the manufacturer is American NEB company; g418, Producer Gibco USA.
Example 1 optimized synthesis of Aspergillus niger GOD Gene and construction of expression Strain
(1) Sequence optimization design and expression vector construction
An Aspergillus niger GOD gene sequence SEQ ID NO.1 (accession number: MH593586.1) disclosed by GenBank is optimally designed, a pichia pastoris high-frequency codon is used for replacing a low-frequency codon, enzyme cutting sites such as EcoRI, Xba I and Sac I are removed, the content of AT base in the sequence is manually adjusted, and a plurality of continuous A, T base is avoided. Then, the whole gene synthesis is carried out (the sequence is shown in SEQ ID NO. 2). The synthetic sequence was named GOD-opt, and EcoRI and Xba I cleavage sites were introduced at the 5 'and 3' ends of the GOD-opt, respectively. The GOD-opt and pPICz alpha A vectors are respectively cut by EcoRI and Xba I, and the specific reaction system is shown in Table 1.
TABLE 1 GOD-opt and pPICzaA restriction enzyme digestion systems
Figure BDA0003511412630000051
The temperature is kept at 37 ℃ for 5 h. Then, the DNA was purified using a DNA column purification kit (product of Omega Co.), and ligation was performed, and the reaction system was as shown in Table 2.
TABLE 2 ligation reaction System
Figure BDA0003511412630000052
The cells were incubated at 16 ℃ for 12h, transformed into E.coli Top10 competent cells (purchased from New Provisions Ltd. of Beijing Ongchon), and coated with low-salt LB plates (10g/L tryptone, 5g/L yeast extract, 5g/L NaCl, 15g/L agar, 25mg/L zeocin) containing the antibiotic zeocin. Cultured overnight at 37 ℃, and single colonies are picked and streaked on low-salt LB plates. And extracting plasmids, sequencing by using primers AOX-F and AOX-R, and confirming that the sequence connection is correct. The recombinant expression vector was named pPIC-GOD-opt. The primer sequences are shown in Table 3.
TABLE 3 primer sequences used for sequencing
Figure BDA0003511412630000053
(2) Constructing a recombinant strain:
the pPIC-GOD-opt is linearized by Sac I restriction endonuclease, cut at 37 ℃ for more than 12h, then the cut product is purified by a DNA column purification kit and dissolved in 10 mu L of sterilized ddH2And (4) in O. The specific reaction system is shown in Table 4.
TABLE 4 linearization of recombinant expression vectors
Figure BDA0003511412630000061
A single colony of Pichia pastoris X33 was inoculated into 5mL of YPD medium (1% yeast extract, 2% peptone, 2% glucose) and cultured overnight at 30 ℃ under shaking at 220 rpm. Transferring 50mLYPD medium at 1%, and shaking at 30 deg.C and 220rpm until OD600The cells are collected by centrifugation at 5000rpm for 5min at 4 ℃ and about 1.0, washed with ice-cold sterilized water for 2-3 times, and dissolved in 1mL of 1M sorbitol to obtain competent cells. mu.L of linearized pPIC-GOD-opt was added to 100. mu.L of competent cells, mixed well, added to a cuvette, shocked at 2000V for 5mS, immediately added to 1mL of ice-cold 1M sorbitol solution, and then re-incubated at 30 ℃ for 3 h. YPDS plates (1% yeast extract, 2% peptone, 2% glucose, 1.5% agar, 1M sorbitol) containing 100. mu.g/mL zeocin were spread and cultured at 30 ℃ for 3-4 days until colonies were clear. The recombinant strain was named X33/GOD.
(3) Identification of recombinant strains
The recombinant strain X33/GOD was inoculated into 5mL of YPD medium and cultured overnight at 30 ℃ with shaking at 220 rpm. mu.L of each was inoculated into 10mL of BMGY medium, and shaking culture was continued at 30 ℃ and 220rpm for 24 hours. The cells were centrifuged at 5000rpm at 4 ℃ for 5min to collect the cells, and the genomic DNA was extracted using a fungal DNA extraction kit (product of Omega). PCR amplification was performed. The amplification system is shown in Table 5. Amplification conditions: 30 cycles of 94 ℃ for 30s, 55 ℃ for 20s, and 72 ℃ for 2 min. Detecting the amplification product by agarose gel electrophoresis.
TABLE 5 PCR amplification System
Figure BDA0003511412630000071
Example 2 cloning of Pichia pastoris FAD synthetase Gene and construction of expression vector
(1) Cloning of FAD synthetase gene:
primers were designed based on the genomic sequence of Pichia pastoris (accession No. LT962476) published in GenBank, and the FAD synthetase sequence (SEQ ID NO.3) was amplified, with the primer sequences shown in Table 6. Inoculating Pichia pastoris X33 into YPD liquid culture medium, shake culturing at 30 deg.C for 18h, centrifuging at 5,000rpm for 5min, and collecting thallus. Genomic DNA was extracted using a fungal DNA extraction kit (product of Omega).
TABLE 6 primer sequences for cloning FAD synthetase genes
Figure BDA0003511412630000072
And amplifying FAD synthetase gene by PCR. The amplification system is shown in Table 7. Amplification conditions: 30 cycles of 94 ℃ for 30s, 58 ℃ for 20s, and 72 ℃ for 1 min. Detecting the amplification product by agarose gel electrophoresis. 1 band of about 800bp was amplified.
TABLE 7 FAD synthetase gene PCR amplification System
Figure BDA0003511412630000073
Figure BDA0003511412630000081
(2) Construction of an expression vector:
the double digestion reaction system of the PCR product and the expression vector pGAPkA is shown in Table 8.
TABLE 8 double digestion of FAD synthetase gene with expression vector pGAPkA
Figure BDA0003511412630000082
The temperature is kept at 37 ℃ for 5 h. Then, the DNA was purified using a DNA column purification kit (product of Omega Co.), and ligation was performed, and the reaction system was as shown in Table 9.
TABLE 9 ligation reaction System
Figure BDA0003511412630000083
Ligation was carried out at 16 ℃ for 12 h. E.coli Top10 competent cells were transformed. Low salt LB plates containing the antibiotic zeocin were coated. Cultured overnight at 37 ℃, and single colonies are picked and streaked on low-salt LB plates. And extracting plasmids, sequencing by using a primer AOX-R, and confirming that the sequence connection is correct. The recombinant expression vector was named pGAP-FAD.
Example 3 construction of a Strain in which FAD synthetase Gene and GOD Gene are coexpressed
A single X33/GOD colony was inoculated into 5mL YPD medium and cultured overnight at 30 ℃ with shaking at 220 rpm. Transferring 50mL YPD medium at 1%, shaking at 30 deg.C and 220rpm until OD600The cells were collected by centrifugation at 4 ℃ and 5,000rpm for 5min at about 1.0, washed with ice-cold sterile water 2-3 times, and dissolved in 1mL of 1M sorbitol to give competent cells.
The recombinant plasmid pGAP-FAD was linearized with the restriction enzyme Bgl II, the digestion system is shown in Table 10. The temperature is kept at 37 ℃ for 5 h. Then, the DNA was purified by using a DNA column purification kit (product of Omega Co.), and the DNA was dissolved in 10. mu.L of ddH2O。
TABLE 10 linearization of pGAP-FAD
Figure BDA0003511412630000091
10 μ L of linearized pGAP-FAD were shock-transformed into X33/GOD competent cells at 2000V, 5mS, plated with YPDS plates (1% yeast extract, 2% peptone, 2% glucose, 1.5% agar, 1M sorbitol) containing 100 μ G/mL antibiotic G418, and cultured at 30 ℃ for 3-4 days until colonies were clear. The recombinant strain was named X33/GOD-FAD.
Example 4 Shake flask fermentation
(1) And (3) shake flask fermentation culture:
recombinant Pichia pastoris strains X33/GOD, X33/GOD-FAD-1, X33/GOD-FAD-2, X33/GOD-FAD-3 and X33/GOD-FAD-4 (all randomly selected clones) are picked and inoculated into YPD liquid culture medium respectively, and shaking culture is carried out at 220rpm at 30 ℃ overnight. 1% was transferred to 20mL BMGY (1% yeast extract, 2% peptone, 1.34% YNB, 4X 10-5% biotin, 1% glycerol, 100mM phosphate buffer pH 6.0) in a 250mL shake flask and shake-cultured at 30 ℃ and 220rpm to OD600The value is 2-6, and the thalli are collected by centrifugation at 5000rpm and 4 ℃ for 5 min. The cells were incubated with 20mL BMMY medium (1% yeast extract, 2% peptone, 0.1mol/L phosphate buffer pH 6.0, 1.34 percent YNB, 4 × 10-5 percent biotin), shaking culture at 30 ℃ and 220rpm, adding absolute methanol with the final concentration of 0.5 percent (V/V) for shake flask induction culture, adding methanol once every 24h, centrifuging to take supernatant, and storing at 4 ℃ for testing.
(2) And (3) enzyme activity analysis:
diluting a glucose oxidase standard substance into 0.4, 0.8, 1.2, 1.6, 2.0 and 2.4U/mL, adding 500 mu L of o-dianisidine buffer solution, 60 mu L of 1M glucose and 20 mu L of 100U/mL horseradish peroxidase solution into a 1.5mL centrifuge tube, preserving the temperature for 5min at the determination temperature, adding 20 mu L of diluted glucose oxidase standard substance, adding 100 mu L of 2mol/L sulfuric acid to terminate the reaction after reacting for 3min, adding 200 mu L of reaction liquid into a 96-well plate, determining the light absorption value of the reaction liquid at 460nm by using a microplate reader, and making an enzyme activity-light absorption value curve, namely the standard curve under the reaction condition.
Diluting the crude enzyme solution by corresponding times, replacing the standard substance in the same step, measuring the light absorption value, adding the reaction termination solution and the enzyme solution as a blank control, and calculating the enzyme activity under the reaction condition according to the standard yeast. The results are shown in FIG. 2, and the fermentation activities of the strains X33/GOD are 100%, X33/GOD-FAD-1 is 220%, X33/GOD-FAD-2 is 228%, X33/GOD-FAD-3 is 235%, and X33/GOD-FAD-4 is 216%. The transfer of the FAD synthetase is proved, and the fermentation activity of the GOD is obviously improved.
(3) SDS-PAGE electrophoresis of supernatant proteins:
a12.5% SDS-PAGE gel was prepared, and 10. mu.L of each of the fermentation supernatants was sampled to compare the brightness of the protein bands. As shown in FIG. 3, the brightness of the protein band of the co-expressed FAD synthetase is obviously higher than that of X33/GOD, which indicates that the transfer of FAD synthetase improves the GOD protein expression level. Quantitative analysis of the expressed protein by using a BSA quantitative kit shows that the GOD expression level of the strain co-expressing FAD is improved by about 1 time (see Table 11).
TABLE 11 recombinant strain fermentation supernatant protein quantification and fermentation viability results
Strain numbering Protein content (mg/mL) Fermentation vigor (U/mL)
X33/GOD 1.32 145
X33/GOD-FAD-1 2.90 320
X33/GOD-FAD-2 3.01 330
X33/GOD-FAD-3 3.10 340
X33/GOD-FAD-4 2.85 313
Comparative example 1
The sequence of the GOD gene which is optimized only by software and is not adjusted manually is shown as SEQ ID NO.8 in the comparative example.
The procedure for obtaining SEQ ID NO.8 in this comparative example is the same as the sequence optimization procedure of example 1, except that the GOD gene sequence of SEQ ID NO.8 used in this comparative example was completely generated by software without manual adjustment.
When a co-expression strain is constructed by adopting a gene sequence shown in SEQ ID NO.8, the fermentation activity of glucose oxidase generated by the strain with the co-expression of FAD synthetase gene and GOD gene is found to be 140U/mL, and is basically similar to that of a strain with single expression of GOD gene. And the fermentation activity of the glucose oxidase obtained by the comparative example is obviously lower than the GOD fermentation activity of the co-expression strain obtained by the example 3.
When a co-expression strain is constructed by adopting a gene sequence shown in SEQ ID NO.8, the GOD expression quantity of the strain co-expressing the FAD synthetase gene and the GOD gene is 1.30mg/mL and is basically similar to the GOD expression quantity of the strain singly expressing the GOD gene.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Sequence listing
<110> university of agriculture in China
<120> method for improving expression efficiency of glucose oxidase gene in pichia pastoris
<130> KHP221110429.2
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1761
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
tacatcagga gcaatggcat tgaagccagc ctcctgactg accccaagga tgttaccggc 60
cgcactgtcg actacatcat cgctggtgga ggtctgactg gactcactac tgctgcccgt 120
ctgacggaga accccaatat cactgtgctt gtcatcgaaa gtggctccta cgagtctgac 180
agaggtccta tcattgagga cctgaacgct tacggtgaca tttttggcag cagtgtggac 240
cacgcctacg agactgtcga gctcgccacc aacaatcaga ctgcgctaat ccgctccgga 300
aatggtctcg gtggctctac cctcgtcaac ggtggcacct ggactcgccc ccacaaggca 360
caagttgact cgtgggagac cgtcttcgga aatgagggct ggaactggga cagcgtggcc 420
gcctactccc tccaggctga gcgtgctcgc gcaccaaatg ccaaacagat tgctgctggc 480
cactacttta atgcatcctg ccatggtctc aatggtactg tccacgccgg accccgcgat 540
accggtgatg actactcccc catcgtcaag gctctcatga gcgttgtcga agacaggggc 600
gtccccacca agaaggactt gggatgcggt gacccccatg gtgtgtccat gttccccaac 660
accttgcacg aagaccaagt gcgctctgat gccgctcgcg aatggctcct ccccaactac 720
cagcggccca acctgcaagt cctcactgga cagtatgttg gaaaggttct gctcagccag 780
aacgctacca cacctcgtgc cgttggcgtg gaattcggca cccacaaggg caacacccac 840
aacgtctacg ctaagcacga ggtcctccta gccgctggat ccgcggtctc tcccaccatc 900
ctcgaatatt ccggtatcgg aatgaagtcc attctggagc ctcttggaat tgacaccgtc 960
gttgacctgc ccgtcggtct caaccttcag gaccagacca cctctaccgt ccgctcacgc 1020
attacctccg ccggtgccgg acagggacag gccgcttggt tcgctacctt caacgagacc 1080
tttggcgact acaccgaaaa ggcccacgag ctgctcaaca ccaagctgga gcagtgggcc 1140
gaagaggccg tcgcccgtgg cggattccac aacaccaccg ctttgctcat ccagtacgag 1200
aactaccgcg actggatcgt caaggacaat gtcgcatact cggaactctt cctcgacacg 1260
gccggagtgg ccagtttcga tgtgtgggat cttctgccct tcactagagg atacgtccac 1320
atcctcgaca aggaccccta cctccgccat ttcgcctacg accctcagta cttcctcaac 1380
gagcttgacc tgctcggcca ggctgccgcc actcagctgg cccgcaacat ctccaactcc 1440
ggtgccatgc aaacttattt cgctggagag actattcccg gtgacaacct cgcgtatgat 1500
gccgacttga gcgcctgggt tgagtatatc ccgtacaact tccgccctaa ctaccatggt 1560
gtgggtactt gctccatgat gccgaaggag atgggcggtg ttgtcgacaa tgctgcccgt 1620
gtgtatggtg tgcagggact gcgagtcatc gatggttcta ttccccctac gcaaatgtcg 1680
tcccatgtta tgacggtctt ttatgccatg gccttgaaga ttgcggatgc cgtcttggcg 1740
gattatgctt ccatgcagtg a 1761
<210> 2
<211> 1773
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
gaattctata ttagatccaa cggaatagaa gcatcacttc ttaccgatcc taaagacgtt 60
accggaagga ccgtcgacta tattattgct ggtggaggtc ttactggatt aactaccgct 120
gccaggttga cagagaatcc aaatatcact gtactggtta ttgaatcagg cagttatgaa 180
agtgataggg gtccaataat tgaggacctt aacgcttacg gtgacatctt tggatcttca 240
gttgaccatg cctatgaaac agttgagctt gccactaaca atcagactgc acttattaga 300
tccggaaacg gtcttggtgg atctactctt gttaatggtg gtacttggac caggcctcat 360
aaagcccaag tcgattcatg ggagactgtt ttcggaaatg agggctggaa ctgggattcc 420
gtcgcagctt acagtcttca agctgaaaga gccagagcac caaatgctaa gcaaattgct 480
gccggacact acttcaatgc atcctgtcac ggacttaatg gaactgtaca tgctggtcct 540
cgagatacgg gagatgatta ttctccaatc gttaaggctt taatgtcagt cgtagaagat 600
agaggtgttc ctactaagaa agatttgggt tgtggtgacc cccatggtgt ttccatgttt 660
ccaaacactc tgcatgaaga tcaagtacgt tctgacgccg ctagagaatg gctattacct 720
aactaccaga ggcccaattt gcaagtgctg actggacaat atgttggaaa ggtattactg 780
tcacagaacg ccactacccc aagggccgtt ggtgtagagt tcggtactca taaaggaaac 840
acacacaacg tttacgctaa acatgaagtc cttcttgccg caggttctgc tgtatcaccc 900
accatactgg aatactccgg tattggcatg aagtctattc tggaaccact gggtattgat 960
actgtagtcg acttacctgt tggcttgaac ttgcaagatc aaaccacttc taccgtcagg 1020
tccagaatca cttccgcagg tgcaggacaa ggtcaagccg cctggtttgc tacctttaac 1080
gaaacctttg gcgattatac agagaaagct cacgaactgc ttaacactaa gctagagcaa 1140
tgggctgaag aagctgtggc tcgtggtggt ttccataaca ccactgcttt attgatacaa 1200
tacgaaaact atagggattg gatcgttaag gataacgtcg cttattccga gctgttttta 1260
gataccgccg gagttgcttc ttttgatgtt tgggatttac tacccttcac acgtggatac 1320
gtccatattt tagacaagga tccttacttg agacattttg cttatgaccc tcaatacttc 1380
ctgaacgaat tggacttgtt gggccaagcc gccgcaactc agcttgctcg aaatatttca 1440
aactctggag caatgcaaac ctattttgct ggagaaacta tccctggtga taatcttgca 1500
tatgacgccg atctttctgc ctgggtagag tacatacctt acaacttcag acctaactac 1560
catggagtag gaacttgctc aatgatgcca aaagaaatgg gcggagttgt ggacaacgct 1620
gctagagtat acggtgtgca aggtcttcga gttatcgacg gaagtattcc acctactcag 1680
atgtcctccc acgtgatgac agtattttat gctatggctc ttaaaattgc tgatgctgtg 1740
cttgctgact acgctagtat gcagtaatct aga 1773
<210> 3
<211> 807
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
gaattcatgg taactgttct ctccaatagt agtaagcaga ccacacagat tcagcacaat 60
cacaatatga taaaagactc atttctctca gtgtgtgaac acagctataa ccttatcact 120
gattttttga atgagtcaga tcctgaaaac gaacttttga catcgaccca ggaacaggtc 180
agaaaatcct atgacatact ctttgaatct ttgaacttgt acaaattaga tgaactatca 240
atatcatata acggcggaaa agactgtctt gtactgctga tcatttactt agcagtcatt 300
tacgataaat atcaaaacga gtcgatacca agggattaca aattaaacgc actatacatc 360
aaaaatgagt caatgttcca agaacaggac gatttcataa aaaaatcggc ggcaaaatac 420
cagctaaatc tacagccatt tagagacact atgaagagag ctctccacaa atatttggta 480
caaaacccat gcataaaagc cgtcattata ggcatcagaa gatgtgatcc atatggtaag 540
gatttacatt atttacaaga aacagatcca agctggcccc ggctaatgcg ggtcaatccg 600
attctggaat gggattacca ccaaatttgg ttcttcctcc gtcatttaaa aatagaatac 660
tgcaagctct atgatatggg ctatacttct ctgggtggta ccaacaacac tattaagaac 720
cctgacctgc aggacggtga tggctatctt cctgcgtact tgctggatga ttccgaaaag 780
gaaagatcca gtagattatg atctaga 807
<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gactggttcc aattgacaag c 21
<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
gcaaatggca ttctgacatc c 21
<210> 6
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
ggaattcatg gtaactgttc tctcc 25
<210> 7
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
gctctagatc ataatctact ggatct 26
<210> 8
<211> 1761
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
tatattcgtt caaacggcat cgaggcttct ctgttaaccg atcccaaaga cgtcaccggt 60
agaactgtgg attatattat tgccggaggt ggtctgacag gtttgacaac cgccgctcgt 120
ttaactgaga accctaatat tacggttttg gttatcgaaa gtggttcata tgagtccgat 180
agaggcccaa taattgaaga tttgaatgct tacggtgata ttttcggttc cagtgtagac 240
catgcttacg agactgttga acttgctacg aataaccaaa ccgccttaat tagatcagga 300
aatggcttag gtggttccac attagttaat ggtggcacat ggacaagacc acacaaggct 360
caggtcgatt catgggaaac tgtttttgga aacgaaggat ggaattggga ttctgtcgca 420
gcatattcct tacaagctga acgtgctagg gccccaaacg ctaaacaaat tgctgcagga 480
cattatttca acgcctcttg tcatggacta aacggaaccg tacatgcagg acctagagac 540
actggtgatg attactctcc aattgttaaa gcactgatgt ccgttgttga agatagaggt 600
gtcccaacaa agaaagattt aggttgtggt gaccctcatg gcgtttctat gtttccaaac 660
actttgcacg aagatcaggt caggtccgac gcagctcgtg agtggctttt accaaactac 720
caaagaccaa acttgcaagt cttgaccggt caatacgtag gaaaggttct attgagtcaa 780
aacgccacta caccaagagc cgtgggtgtt gagtttggaa cccataaagg taatacgcac 840
aacgtttacg caaagcacga agtcctactt gctgcaggtt ccgctgtttc tccaacaatt 900
cttgagtaca gtggaatcgg catgaaatcc atattagaac cacttggaat tgacaccgtg 960
gttgacttgc ctgtcggact gaacttgcag gatcaaacga cctcaaccgt tagaagtaga 1020
atcacttctg ctggcgcagg tcaaggtcaa gcagcttggt tcgctacgtt caatgaaact 1080
tttggtgact ataccgaaaa agctcacgaa ttattgaata ccaaattgga gcaatgggct 1140
gaggaagctg tagctagagg aggatttcac aacaccacag cacttttaat tcagtatgag 1200
aactacagag actggatcgt gaaggataat gtggcctatt ctgaactgtt cttggatacc 1260
gccggtgtcg catccttcga tgtgtgggac ttgttgcctt ttactagagg ttacgtccac 1320
attttggata aagacccata cttaagacac tttgcttacg accctcaata ttttctgaac 1380
gaattggact tgctgggaca ggctgccgca acacagcttg cacgtaatat atccaactcc 1440
ggtgctatgc agacttattt tgctggcgaa actatcccag gagacaacct tgcttatgac 1500
gctgatttgt cagcatgggt tgagtatatt ccatacaact ttcgtcctaa ttaccatggt 1560
gtgggaactt gttctatgat gccaaaggaa atgggtggtg tagttgacaa tgctgcccga 1620
gtctacggtg ttcaaggttt gagagttatc gacggctcca ttccccctac tcaaatgtca 1680
agtcacgtca tgacagtttt ctacgctatg gctcttaaga ttgctgatgc tgttttggct 1740
gattatgcca gtatgcaata a 1761

Claims (10)

1. The glucose oxidase gene sequence is characterized in that the glucose oxidase gene sequence is shown as SEQ ID No. 2.
2. An expression vector comprising the glucose oxidase gene sequence of claim 1.
3. A recombinant bacterium comprising the glucose oxidase gene sequence of claim 1.
4. The recombinant strain as claimed in claim 3, wherein the recombinant strain simultaneously expresses a glucose oxidase gene sequence shown by SEQ ID No.2 and a flavin adenine dinucleotide synthetase gene sequence shown by SEQ ID No. 3.
5. A method for improving activity and expression efficiency of glucose oxidase is characterized in that a recombinant bacterium co-expressed by a glucose oxidase gene sequence shown in SEQ ID No.2 and a flavin adenine dinucleotide synthetase gene sequence shown in SEQ ID No.3 is constructed.
6. The method according to claim 5, characterized in that the vector pPICz α A is used to construct a recombinant expression vector pPIC-GOD-opt containing the glucose oxidase gene sequence shown in SEQ ID No. 2; an expression vector pGAP-FAD containing a flavin adenine dinucleotide synthetase gene sequence shown in SEQ ID NO.3 is constructed by using the vector pGAPkA.
7. The method of claim 5, comprising:
(1) optimizing the gene sequence shown in SEQ ID NO.1 to obtain a glucose oxidase gene sequence GOD-opt shown in SEQ ID NO.2, and respectively introducing EcoRI enzyme cutting sites and Xba I enzyme cutting sites at the 5 'end and the 3' end of the GOD-opt;
(2) carrying out enzyme digestion on the GOD-opt and the pPICz alpha A vector by EcoRI and Xba I respectively to obtain a recombinant expression vector pPIC-GOD-opt;
(3) linearizing the pPIC-GOD-opt by using Sac I restriction endonuclease, and transferring the linearized pPIC-GOD-opt into a pichia pastoris competent cell to obtain a recombinant strain X33/GOD;
(4) carrying out double enzyme digestion on a gene sequence shown in SEQ ID NO.3 and an expression vector pGAPkA to obtain a recombinant expression vector pGAP-FAD;
(5) and transferring the recombinant expression vector pGAP-FAD into a recombinant bacterium X33/GOD to obtain a strain X33/GOD-FAD with the co-expression of FAD synthetase genes and GOD genes.
8. The method according to claim 7, wherein the primer sequence used for synthesizing the gene sequence shown in SEQ ID No.3 is shown in SEQ ID No. 6-7.
9. Use of the glucose oxidase gene sequence of claim 1 or the recombinant bacterium of any one of claims 3-4 for increasing the expression level of glucose oxidase.
10. Use of the glucose oxidase gene sequence of claim 1 or the recombinant bacterium of any one of claims 3-4 for increasing the expression activity of glucose oxidase.
CN202210153176.5A 2022-02-18 2022-02-18 Method for improving expression efficiency of glucose oxidase gene in pichia pastoris Active CN114410662B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210153176.5A CN114410662B (en) 2022-02-18 2022-02-18 Method for improving expression efficiency of glucose oxidase gene in pichia pastoris

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210153176.5A CN114410662B (en) 2022-02-18 2022-02-18 Method for improving expression efficiency of glucose oxidase gene in pichia pastoris

Publications (2)

Publication Number Publication Date
CN114410662A true CN114410662A (en) 2022-04-29
CN114410662B CN114410662B (en) 2024-02-06

Family

ID=81260980

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210153176.5A Active CN114410662B (en) 2022-02-18 2022-02-18 Method for improving expression efficiency of glucose oxidase gene in pichia pastoris

Country Status (1)

Country Link
CN (1) CN114410662B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058637A (en) * 2021-03-31 2022-02-18 山西大禹生物工程股份有限公司 Efficient expression method of aspergillus niger glucose oxidase gene

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105936910A (en) * 2016-07-06 2016-09-14 青岛红樱桃生物技术有限公司 Optimized glucose oxidase gene GOD, expression vector and applications thereof
CN106011093A (en) * 2016-07-06 2016-10-12 青岛红樱桃生物技术有限公司 Glucose oxidase mutant GOD-M01 with improved enzymatic activity and expression vector and application of glucose oxidase mutant GOD-M01
CN109321586A (en) * 2018-11-03 2019-02-12 中国农业科学院生物技术研究所 Recombinant Aspergillus niger Glucose Oxidase optimization gene and its expression vector and application
CN110819642A (en) * 2019-11-28 2020-02-21 山东省科学院生物研究所 Codon-optimized FAD-glucose dehydrogenase gene and application thereof
CN114058637A (en) * 2021-03-31 2022-02-18 山西大禹生物工程股份有限公司 Efficient expression method of aspergillus niger glucose oxidase gene

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105936910A (en) * 2016-07-06 2016-09-14 青岛红樱桃生物技术有限公司 Optimized glucose oxidase gene GOD, expression vector and applications thereof
CN106011093A (en) * 2016-07-06 2016-10-12 青岛红樱桃生物技术有限公司 Glucose oxidase mutant GOD-M01 with improved enzymatic activity and expression vector and application of glucose oxidase mutant GOD-M01
CN109321586A (en) * 2018-11-03 2019-02-12 中国农业科学院生物技术研究所 Recombinant Aspergillus niger Glucose Oxidase optimization gene and its expression vector and application
CN110819642A (en) * 2019-11-28 2020-02-21 山东省科学院生物研究所 Codon-optimized FAD-glucose dehydrogenase gene and application thereof
CN114058637A (en) * 2021-03-31 2022-02-18 山西大禹生物工程股份有限公司 Efficient expression method of aspergillus niger glucose oxidase gene

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
石义超: "葡萄糖氧化酶基因在毕赤酵母中的高效表达研究", 硕士电子期刊 *
魏东升: "葡萄糖氧化酶在毕赤酵母中的高效分泌表达", 硕士电子期刊 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058637A (en) * 2021-03-31 2022-02-18 山西大禹生物工程股份有限公司 Efficient expression method of aspergillus niger glucose oxidase gene

Also Published As

Publication number Publication date
CN114410662B (en) 2024-02-06

Similar Documents

Publication Publication Date Title
EA023764B1 (en) Genetically modified cell and process for use of said cell
EA025990B1 (en) Polypeptides having oxidoreductase activity and their uses
CN109055324B (en) Improved ketoreductase and application thereof
CN105647822B (en) Recombinant mortierella alpina for overexpression of omega-3 desaturase from phytophthora parasitica as well as construction method and application thereof
US20220220454A1 (en) Thermostable glucose oxidase
CN114410662B (en) Method for improving expression efficiency of glucose oxidase gene in pichia pastoris
CN114058637A (en) Efficient expression method of aspergillus niger glucose oxidase gene
CN109666592B (en) Fungal laccase expression strain and construction method and application thereof
CN114736881B (en) Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof
CN110894219A (en) Pichia pastoris transcription factor HAC1, protein, pichia pastoris and preparation and application thereof
CN114891707B (en) Recombinant strain and method for producing bilirubin by whole cell catalysis thereof
CN113136382B (en) Method for synthesizing glyoxylic acid by utilizing corynebacterium glutamicum based on CRISPII regulation and control
CN112410353B (en) fkbS gene, genetic engineering bacterium containing fkbS gene, and preparation method and application of fkbS gene
CN108441508B (en) Application of bacillus licheniformis DW2 DeltalrPC in bacitracin production
CN114806902B (en) Method for obtaining non-transgenic trichoderma reesei targeted genetic engineering improved strain and application
CN108676080B (en) Aureobasidium pullulans carbon response transcription factor Cat8, and recombinant expression vector and application thereof
CN114480315B (en) Baeyer-Villiger monooxygenase and application thereof in brivaracetam synthesis
KR20190029964A (en) Novel recombinant E. coli strains and method for producing 3- hydroxypropionic acid using thereof
CN116333944B (en) Arthrobacter C2 and application of recombinant Arthrobacter in lignin degradation
RU2813283C2 (en) Recombinant strain based on escherichia coli, a method of its construction and use
CN117247924A (en) Ame1-FgTad2-FgTad3 editing enzyme system, editing tool and editing method
Wang et al. Construction of SHP-GLOX Straw Lignin Degulation System and Its Application Effect in Rice
CN114561302A (en) Aspergillus niger strain with high citric acid yield, method and application
CN116121162A (en) Recombinant streptomyces node for eliminating byproducts, construction method and application
CN112592879A (en) Recombinant Gluconobacter oxydans engineering bacterium and application thereof in synthesizing miglitol intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant